Literature DB >> 12117972

Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils.

Kevin O Kisich1, Michael Higgins, Gill Diamond, Leonid Heifets.   

Abstract

The ability of human neutrophils to aid in defense against pulmonary infection with Mycobacterium tuberculosis is controversial. In this study, we have shown that neutrophils respond to and phagocytose M. tuberculosis in human lesions. Neutrophils from healthy individuals were able to kill significant fractions of an inoculum of M. tuberculosis within 1 h of phagocytosis, and this ability was enhanced by tumor necrosis factor alpha but not by gamma interferon. The mycobactericidal mechanism was nonoxidative, as inhibitors of reactive oxygen or reactive nitrogen intermediates did not interfere with killing. However, the mycobactericidal mechanism was associated with increased exposure of intracellular M. tuberculosis to neutrophil defensins. In vitro, human neutrophil peptides 1 to 3 were not able to kill the bacilli even at much higher levels. These studies support the concept that human neutrophils are directly involved in defense against infection with M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117972      PMCID: PMC128192          DOI: 10.1128/IAI.70.8.4591-4599.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.

Authors:  G Cotter; E Kaluski; A Blatt; O Milovanov; Y Moshkovitz; R Zaidenstein; A Salah; D Alon; Y Michovitz; M Metzger; Z Vered; A Golik
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  Antibacterial activity of cationic proteins from human granulocytes.

Authors:  H Odeberg; I Olsson
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  Capacity of human neutrophils to kill Mycobacterium tuberculosis.

Authors:  A E Brown; T J Holzer; B R Andersen
Journal:  J Infect Dis       Date:  1987-12       Impact factor: 5.226

4.  Antibiotic proteins of human polymorphonuclear leukocytes.

Authors:  J E Gabay; R W Scott; D Campanelli; J Griffith; C Wilde; M N Marra; M Seeger; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase.

Authors:  A R Cross; O T Jones
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

6.  Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis.

Authors:  K O Kisich; L Heifets; M Higgins; G Diamond
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis.

Authors:  M E May; P J Spagnuolo
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Correlation of binding of rabbit granulocyte peptides to Candida albicans with candidacidal activity.

Authors:  R I Lehrer; D Szklarek; T Ganz; M E Selsted
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

9.  Defensins. Natural peptide antibiotics of human neutrophils.

Authors:  T Ganz; M E Selsted; D Szklarek; S S Harwig; K Daher; D F Bainton; R I Lehrer
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

10.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria.

Authors:  G S Douvas; D L Looker; A E Vatter; A J Crowle
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

View more
  46 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

2.  Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity.

Authors:  Ernestas Janulionis; Carolina Sofer; Stephan K Schwander; Denarra Nevels; Barry Kreiswirth; Elena Shashkina; Robert S Wallis
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

Review 3.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 4.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

5.  Mycobacterium tuberculosis Infection of the placenta: a study of the early (innate) inflammatory response in two cases.

Authors:  Carlos R Abramowsky; Julie Gutman; Joseph A Hilinski
Journal:  Pediatr Dev Pathol       Date:  2012-01-19

6.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.

Authors:  Geraldine Nouailles; Anca Dorhoi; Markus Koch; Jens Zerrahn; January Weiner; Kellen C Faé; Frida Arrey; Stefanie Kuhlmann; Silke Bandermann; Delia Loewe; Hans-Joachim Mollenkopf; Alexis Vogelzang; Catherine Meyer-Schwesinger; Hans-Willi Mittrücker; Gayle McEwen; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

7.  The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection.

Authors:  Andrew J Olive; Clare M Smith; Michael C Kiritsy; Christopher M Sassetti
Journal:  J Immunol       Date:  2018-07-30       Impact factor: 5.422

Review 8.  The roles of antimicrobial peptides in innate host defense.

Authors:  Gill Diamond; Nicholas Beckloff; Aaron Weinberg; Kevin O Kisich
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

9.  Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis.

Authors:  Sugata Roy; Sadhna Sharma; Monika Sharma; Ramesh Aggarwal; Mridula Bose
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

10.  Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures.

Authors:  Kirti V Sawant; David N McMurray
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.